| EPIC | EDEN |
| Sector | Pharma and Biotech |
| ISIN | GB0001646941 |
| Market Sector | AIM |
| Market Segment | ASQ1 |
| Main Indices | FTSE AIM All-Share |
| Country of register | Great Britain |
| Currency | British Pound |
| Market Cap | £12.80m |
| NMS | 10,000 |
| Shares in issue | 533.35m |
| Date Listed | n/a |
| Currency | UK Pounds |
| Share Price | 2.40p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 4.25 |
| 52 Week Low | 2.10 |
| Volume | 155,172 |
| Shares Issued | 533.35m |
| Market Cap | £12.80m |
| Beta | 0.80 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 16:03 | 100,000 @ 2.10p |
| 13:43 | 172 @ 2.30p |
| 13:12 | 55,000 @ 2.47p |
| CFO | Alexander John Abrey |
| CEO | Sean M. Smith |
You are here: research